康华生物：11月14日召开董事会会议

Group 1 - The core point of the article is that Kanghua Biological announced the convening of its third board meeting via telecommunication on November 14, 2025, to discuss various proposals, including the cancellation of certain sub-proposals for the first extraordinary general meeting of 2025 [1] - For the fiscal year 2024, Kanghua Biological's revenue composition is reported as 92.59% from non-immunization planning vaccines and 7.41% from other sources [1] - As of the time of reporting, Kanghua Biological has a market capitalization of 10.9 billion yuan [1]